KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹34 Cr | ₹14 Cr | ₹20 Cr | ₹29 Cr | ₹21 Cr |
What is the latest Total Non-Current Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹34 Cr |
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹29 Cr |
| Mar2022 | ₹21 Cr |
How is Total Non-Current Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹34 Cr | 149.11 | |
| Mar2025 | ₹14 Cr | -30.35 | |
| Mar2024 | ₹20 Cr | -30.98 | |
| Mar2023 | ₹29 Cr | 34.25 | |
| Mar2022 | ₹21 Cr | - | |
Compare Total Non-Current Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹3,440.7 Cr | 29.4% | 24.5% | 185.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 29.4% |
24.5% |
185.8% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses